Integrating NfL in Routine MS Care: Recommendations from a Systematic Review
A systematic review suggests that interpreting neurofilament light chain (NfL) results in multiple sclerosis requires consideration of four key domains: Biology, Method, Context, and Action. It emphasizes that analytical continuity is crucial to maintain clinical continuity, especially during longitudinal follow-up.
- Tags
- #MSResearch
- Most relevant to
- —
- Human efficacy
- Not established from this source
- Mechanism
- Not reported
- Evidence strength
- Moderate
- Outcome
- Not reported
Why it matters
This integration is important as it addresses how variations in specimen types and analytical methods can influence the clinical interpretation of NfL levels, which are being increasingly utilized in MS management.
What this does not prove
The review highlights that the clinical relevance of NfL results can vary significantly based on the methodology used to generate these results, including the types of specimens and platforms involved.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Systematic review
- Participants / samples
- Not reported
- Randomised
- Not reported
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- All
- Publication date
- 2026-10-24
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Not classified
- Biological target
- Not reported
- Pathway
- Not reported
- Population
- Not reported
- Size of effect
- Not reported
- Secondary endpoints
- Not reported
- MRI endpoints
- Not reported
- Biomarkers
- neurofilament light chain (NfL)
- Safety
- Not reported
Original sources
- Primary evidenceSame biomarker, different number: why multiple sclerosis needs assay-aware NfL interpretation. ↗DOI: 10.1016/j.msard.2026.108016
Supporting passages (8)
study designPublication types: Journal Article
subjectsBlood neurofilament light chain (NfL) is moving from research into routine multiple sclerosis (MS) care, but the clinical meaning of a result depends partly on how that result was generated.
relevant ms typesThis matters particularly during longitudinal follow-up, where a platform change may mimic a biological change and affect interpretation near cut-offs or percentiles.
findingsWe argue that analytical continuity should be treated as part of clinical continuity.
limitationsDifferent specimen matrices and analytical platforms can preserve biological and clinical associations while producing non-interchangeable absolute concentrations.
biomarkersBlood neurofilament light chain (NfL) is moving from research into routine multiple sclerosis (MS) care, but the clinical meaning of a result depends partly on how that result was generated.
publication datePublication date: 2026-10-24
peer reviewedPublication types: Journal Article
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.